| Lekkiah Mazyck, MCD CCC-SLP | |
|
5104 Shamrocks Delight Dr, Bowie, MD 20720-6363 | |
| (301) 237-1078 | |
| Not Available |
| Full Name | Lekkiah Mazyck |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5104 Shamrocks Delight Dr, Bowie, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205009370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202005236 (Virginia) | Secondary |
| 235Z00000X | Speech-language Pathologist | 05297 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lekkiah Mazyck, MCD CCC-SLP 2000 Dornoch Way, Upper Marlboro, MD 20774-9026 Ph: () - | Lekkiah Mazyck, MCD CCC-SLP 5104 Shamrocks Delight Dr, Bowie, MD 20720-6363 Ph: (301) 237-1078 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its SGX301 (synthetic hypericin) development program for the first-line treatment of cutaneous T-cell lymphoma (CTCL) has received "Fast Track" designation from the US Food and Drug Administration.
Ivan Marazzi, PhD, Assistant Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, was awarded $2.5 million in funding by the Chan Zuckerberg Initiative to further the understanding of the underlying causes of neurodegenerative disorders such as Lou Gehrig's, Alzheimer's, and Parkinson's diseases. The
Using positron emission tomography (PET), the medical isotope 15O-water and cold pressor tests, Japanese researchers were able to detect the beginnings of atherosclerosis - before the disease became clinically evident.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
› Verified 2 days ago
Special Education Resources, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6915 Laurel Bowie Rd, Suite 205-f, Bowie, MD 20715 Phone: 240-245-4370 Fax: 240-245-4472 | |
Ebony Brooks, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6915 Laurel Bowie Rd, Ste. 205, Bowie, MD 20715 Phone: 240-245-4370 Fax: 240-245-4472 | |
Mattea A Hermann, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6915 Laurel Bowie Rd Ste 205, Bowie, MD 20715 Phone: 240-245-4370 | |
Eileen L Wallace, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Lyn Pl, Bowie, MD 20715 Phone: 301-602-9121 | |
Ms. Evelyn L. Veney-freeman, MSCCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 901 Westlake Dr, Bowie, MD 20721 Phone: 301-324-8388 Fax: 301-324-1281 | |
Clear Expressions Therapeutic Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12517 Brewster Ln, Bowie, MD 20715 Phone: 202-716-3853 | |
Jessica Teravest, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6915 Laurel Bowie Rd, Ste 205, Bowie, MD 20715 Phone: 240-245-4370 Fax: 240-245-4472 |